Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2005
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596130A Genetic remedies for neurodegenerative diseases
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596123A Interferon therapeutic effect-potentiating agents
03/16/2005CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
03/16/2005CN1596119A Modification of feeding behavior
03/16/2005CN1596118A Therapeutical treatments
03/16/2005CN1596116A Anticancer compositions
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596113A Method of treating depression with delta receptor agonist compounds
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596109A Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
03/16/2005CN1596103A Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/16/2005CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants)
03/16/2005CN1594309A Diphenoxybenzyl compounds having activities of anti-cancer and inhibiting macrophage from releasing NO
03/16/2005CN1593646A Soybean peptide, its preparation and application
03/16/2005CN1593635A Orally disintegrating tablet of 'Huoxiang Zhengqi' and its preparation process
03/16/2005CN1593634A Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process
03/16/2005CN1593627A Orally disintegrating tablet of 'Baibaodan' and its preparation
03/16/2005CN1593546A Method for preparing compound medicinal liquor for nourishing yin
03/16/2005CN1593482A Medicine for treating hypomnesis of middle aged and old man and its preparation process
03/16/2005CN1593473A Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury
03/16/2005CN1593433A Application of agar oligose as a health preserving component
03/16/2005CN1593421A Compound formulation for preventing and treating broiler ascites syndrome
03/16/2005CN1193096C Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193014C Novol pyrrole sulphamide compound
03/16/2005CN1192999C Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
03/16/2005CN1192780C Therapeutical agent
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/16/2005CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/15/2005US6867234 Fat composition for oral or enternal administration and hexacosanoic acid depressant
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867226 Preventing diarrhea
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867215 Cardioprotective phosphonates and malonates
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867204 Benzoxazine derivatives and uses thereof
03/15/2005US6867202 Treatment of insulin resistance
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867190 Methods of therapy with thrombin derived peptides
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005US6867182 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
03/15/2005US6867007 Binary or polynary targeting and uses thereof
03/15/2005US6867003 Grb14, Grb14 fusion proteins, and screening methods
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005US6866838 Composite nanospheres and their conjugates with biomolecules
03/15/2005US6866782 Process for the purification of pharmacologically active proteins through cationic exchange chromatography
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/2005WO2005021792A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021555A1 Bicyclic piperazine compound and use thereof
03/10/2005WO2005021550A1 Bicyclic pyrazole derivative
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021518A1 Condensed ring compound and use thereof
03/10/2005WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005WO2004069236A9 Inhibitor for perioperative blood sugar elevation
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003092720A8 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003079987A3 A non-selective cation channel in neural cells and methods for treating brain swelling
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003072046A3 Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2002087604A8 Preparations containing a combination of vitamin e and afamin
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054728 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents
03/10/2005US20050054726 Vaccine
03/10/2005US20050054717 Coumarin derivative
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054713 3-Substituted oxindole beta3 agonists
03/10/2005US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas
03/10/2005US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
1 ... 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 ... 1564